Himadri Speciality Chemical's Stock Reaches New 52-Week High on Strong Performance

Himadri Speciality Chemical's stock climbed to a new 52-week high of ₹585 on Friday, bucking a broader market downturn. This surge reflects positive investor reaction to the company's robust financial results for the fourth quarter and fiscal year ending March 2026, coupled with its ongoing strategic expansion.

Record Earnings and Expansion Drive Stock

The company's stock saw a significant increase, trading at ₹585 as the BSE Sensex declined by 0.61%. Himadri Speciality Chemical reported its highest-ever full-year EBITDA of ₹1,006 crore, marking a 19% increase year-on-year. Profit After Tax (PAT) for the full year rose 36% year-on-year to ₹755 crore. The fourth quarter of FY26 showed similar strength, with EBITDA growing 21% year-on-year to ₹280 crore and PAT increasing 34% year-on-year to ₹208 crore on revenues of ₹1,288 crore, up 14%. These figures surpassed projections from ICICI Securities, which had forecasted ₹1,240 crore in revenue and ₹200 crore in net profit for the quarter. Trading volumes were substantial, with over 10.89 million shares traded on the NSE and BSE.

Strategic Expansion into High-Growth Segments

A key driver for Himadri is its expansion into speciality carbon black. The company recently commissioned a new 70,000 MTPA line at Mahistikry, West Bengal, establishing the world's largest single-location speciality carbon black facility. This increases its total carbon black capacity to 250,000 MTPA, positioning Himadri among the top five global manufacturers in this segment. These products are targeted at high-value applications in batteries, plastics, and conductive materials. The company is also developing its battery materials business, with Phase I of its Lithium Iron Phosphate (LFP) cathode active material project, at a milestone capacity of 2,000 MTPA, expected to begin by Q3 FY27 and reach full Phase I operations by FY29. An anode production facility with a 200 MTPA capacity is already operational. Additionally, an upcoming anthraquinone and carbazole facility aims to reduce India's dependence on imported dyes and pigments.

Valuation and Peer Comparison

Himadri Speciality Chemical currently trades at a trailing twelve-month (TTM) P/E ratio of approximately 36.54. This valuation is higher than global peers like Cabot Corporation (P/E around 13.25) and domestic conglomerate Reliance Industries (P/E between 22.01 and 24.36). While this premium valuation suggests market expectations for significant growth, it is also viewed against the backdrop of a rapidly expanding Indian specialty chemicals market, projected to reach $93.4 billion by 2034.

Historical Performance

In the prior year's fourth quarter (Q4 FY25), Himadri reported a PAT of ₹155.58 crore. The latest Q4 FY26 results show a substantial 29% year-on-year profit increase. Over the past year, the company's stock has delivered returns of 14.85%, contrasting with a negative 3.06% return for the Sensex.

Challenges and Risks

Despite the strong performance, Himadri faces scrutiny regarding its valuation. The TTM P/E ratio of over 36 is notably higher than established competitors. While future growth prospects in battery materials could justify this premium, failure to meet expectations presents a risk. Concerns include a nearly doubled year-on-year interest burden to ₹17.39 crore in Q4 FY26, leading to a compressed interest coverage ratio. Operating profit margins, excluding other income, decreased to 18.77% in Q4 FY26 from 20.56% a year earlier, indicating potential cost pressures. Analyst sentiment is mixed, with a consensus 'Hold' rating and an average target price of ₹470, suggesting a potential downside. MarketsMOJO had also downgraded the stock to 'Sell' in early March 2026 based on technical indicators. The company's reliance on debt for expansion projects could pose a challenge if profitability falters.

Future Outlook

Himadri Speciality Chemical is strategically positioning itself for continued growth by focusing on high-value segments and prudent capital allocation. The progressive ramp-up of its LFP project and the planned launch of its anthraquinone and carbazole facility are expected to strengthen its market position and reduce import reliance. Management expresses confidence in its ongoing transformation, aiming to develop materials for a sustainable future, and is actively pursuing global supply agreements for its battery materials business. The company's credit rating was reaffirmed at AA- (Positive) by ICRA, indicating a stable outlook for its debt instruments.